Sign Out
Hypersensitivity to bromocriptine, ergot-related or to any of the excipients of Dibor R.
Patients with Syncopal Migraine: Bromocriptine increases the likelihood of a hypotensive episode among patients with syncopal migraine. Loss of consciousness during a migraine may reflect dopamine receptor hypersensitivity. Bromocriptine Dibor R is a dopamine receptor agonist and may therefore, potentiate the risk for syncope in these patients.
Use in lactation: Dibor R is contraindicated in women who are nursing their children. It contains bromocriptine which inhibits lactation. The indication for use of bromocriptine for inhibition of postpartum lactation was withdrawn based on post-marketing reports of stroke in this setting.
